Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only

Temperature excursions and stability assessment

Assess an excursion by matching the recorded exposure to material-specific evidence, without treating a brief departure as automatic failure or automatic acceptability.

A temperature excursion is a departure from the conditions specified for a material. Deciding what it means requires the exposure history and relevant stability evidence, rather than a judgement based only on the highest displayed temperature.

Describe the exposure that needs assessment

Start with the material’s actual stated conditions. Without that reference, a temperature reading cannot establish whether a departure occurred or which limit was exceeded.

Then retain the duration, timing and available temperature sequence. A maximum without a duration leaves a different evidence gap from a full recorded profile.

Original illustrative excursion records
RecordWhat remains unknown
A single high readingHow long it lasted and what happened between observations.
Maximum and minimum onlyThe sequence and cumulative exposure at each condition.
A time-linked seriesWhether the sensor adequately represents the material itself.

A sensor reading describes its measurement location. The report should explain its relevance to the sample, especially if the sensor and material were in different places or packaging layers.

A challenge study can provide directly relevant evidence

Kenley and colleagues investigated the robustness of a formulated pramlintide product using several challenges, including temperature cycling. They measured purity, potency and other formulation attributes and compared results with controls.Kenley and colleagues — Pramlintide formulation robustness studies (opens in a new tab)

The reported attributes remained essentially unchanged, or unchanged relative to controls, under the studied challenges. The conclusion belongs to that multidose formulation and its specified experimental profiles.Kenley and colleagues — Pramlintide formulation robustness studies (opens in a new tab)

This demonstrates the kind of evidence that can inform an excursion assessment. It does not authorise the same exposure for a different peptide, dry material or container.

A useful comparison asks whether the study challenge actually covers the event under investigation. Similar peak temperatures alone do not establish that the duration, sequence and material state also match.

Keep the factual record separate from the disposition

An excursion record answers what happened. A material assessment answers whether the available evidence supports continued suitability. Combining these too early can turn an uncertain observation into an unsupported pass or fail.

For a hypothetical event lasting two hours, a study of a different formulation for one hour does not become a match merely because its temperature was higher. The comparison needs a justified relationship between the exposures.

If there are gaps in the record, preserve them. Do not invent a favourable temperature history, but do not describe an unobserved worst-case history as if it had been measured either.

State which evidence supports the material decision

The assessment should identify the affected material, the excursion profile, the stability evidence used and the requirements being protected. Where the evidence does not cover an attribute, that limitation should remain explicit.

A current analytical result may help, but its scope matters. A single passing assay does not necessarily establish every attribute or the remaining future stability of the material.

When the evidence is insufficient, the next step is a material-specific clarification or investigation through the laboratory’s process. The article cannot supply a universal “safe number of hours” outside the stated conditions.

Sources and further detail

  1. Kenley and colleagues — Pramlintide formulation robustness studies (opens in a new tab)

    Complete original 2000 abstract read. Temperature-cycling and controlled analytical comparisons are used as an evidence example; no handling allowance or clinical-use instruction is reproduced.

Sources checked 20 September 2026. Numerical examples are illustrative unless identified as published observations. This article has not undergone independent scientific peer review.